Synopsys, Inc. $SNPS Shares Bought by Calamos Advisors LLC

Calamos Advisors LLC lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 180.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,854 shares of the semiconductor company’s stock after buying an additional 103,560 shares during the quarter. Calamos Advisors LLC’s holdings in Synopsys were worth $69,962,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Elevation Wealth Partners LLC lifted its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares during the period. North Dakota State Investment Board raised its position in shares of Synopsys by 0.5% during the 3rd quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock valued at $2,482,000 after acquiring an additional 29 shares during the last quarter. Oak Grove Capital LLC lifted its stake in shares of Synopsys by 1.1% in the 3rd quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock valued at $1,260,000 after purchasing an additional 32 shares during the period. Kintegral Advisory LLC boosted its position in shares of Synopsys by 0.6% in the 3rd quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after purchasing an additional 32 shares during the last quarter. Finally, Centaurus Financial Inc. increased its holdings in Synopsys by 2.6% in the first quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock valued at $569,000 after purchasing an additional 36 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

Insider Transactions at Synopsys

In other Synopsys news, insider Aart de Geus sold 24,641 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the completion of the transaction, the insider owned 120,443 shares of the company’s stock, valued at $50,518,611.92. This represents a 16.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. BNP Paribas Exane boosted their target price on Synopsys from $420.00 to $475.00 and gave the stock a “neutral” rating in a research report on Thursday, October 1st. Rothschild & Co Redburn lowered their target price on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 23rd. JPMorgan Chase & Co. lowered their target price on shares of Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $640.00 price objective (up from $590.00) on shares of Synopsys in a research note on Thursday, October 1st. Finally, HSBC lowered Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $575.00.

Synopsys Stock Up 2.3%

SNPS traded up $10.15 during trading on Friday, reaching $450.46. The company had a trading volume of 2,317,784 shares, compared to its average volume of 2,279,157. The company has a market cap of $86.33 billion, a P/E ratio of 79.59, a PEG ratio of 1.48 and a beta of 1.18. Synopsys, Inc. has a 12 month low of $362.55 and a 12 month high of $539.48. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The business’s fifty day moving average price is $441.61 and its 200 day moving average price is $442.27.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the firm earned $3.39 earnings per share. The firm’s revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts anticipate that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its Board of Directors has approved a share repurchase plan on Monday, October 5th that permits the company to repurchase $1 billion in outstanding shares. This repurchase authorization permits the semiconductor company to buy up to 1.1% of its stock through open market purchases. Share repurchase plans are usually an indication that the company’s management believes its stock is undervalued.

Synopsys Company Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.